A phase 2/3, randomized, double blind, placebo-controlled, multicenter study of NKTR-255 vs placebo following CD-19 directed CAR-T therapy in patients with relapsed/refractory large B-cell lymphoma Meeting Abstract
| Authors: | Perales, M. A.; Ahmed, S.; Dahiya, S.; Riedell, P. A.; McGuirk, J. P.; Oluwole, O. O.; Chaudhry, S. A.; Lee, Z.; Dai, S.; Dixit, N.; Fanton, C.; Marcondes, M. Q.; Zalevsky, J.; Tagliaferri, M. A.; Turtle, C. J. |
| Abstract Title: | A phase 2/3, randomized, double blind, placebo-controlled, multicenter study of NKTR-255 vs placebo following CD-19 directed CAR-T therapy in patients with relapsed/refractory large B-cell lymphoma |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 7488 |
| End Page: | 7490 |
| Language: | English |
| ACCESSION: | WOS:000893230300224 |
| DOI: | 10.1182/blood-2022-162511 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
